×

GE.com has been updated to serve our three go-forward companies.

Please visit these standalone sites for more information

GE Aerospace | GE Vernova | GE HealthCare 

Press Release

GE Vernova’s aeroderivative technology to power 150 MW reserve power plant in Tarbert, Ireland

November 15, 2023
  • Three highly flexible GE Vernova LM6000* Aeroderivative gas turbines will be installed at SSE’s Tarbert site
  • The power output of up to 150 megawatts (MW) produced will not be available to the open electricity marketplace and will only be operated against a specific instruction to support the Irish grid when needed
  • With this project, GE Vernova's aeroderivative technology is expected to secure more than 1,1 gigawatts (GW) of reserve power in Europe 

Tarbert, Ireland: November 15, 2023— On the heels of a series

For media inquiries, please contact:

Laura Aresi
Public Relations Leader, Gas Power
GE Vernova
[email protected]
business unit
tags
Press Release

GE Vernova secures eight-unit Aeroderivative order from the Electricity Supply Board of Ireland (ESB)

July 27, 2023
  • Following ESB’s 200 MW North Wall Power Plant powered by six LM2500XPRESS*, eight new LM2500XPRESS aeroderivative gas turbines will be installed by GE Vernova at Shannonbridge Power Plant
  • Shannonbridge Power Plant is expected to provide an additional 264 megawatts (MW) of fast and flexible reserve power up to the end of the 2026-27 winter season

Dublin, Ireland – July 27, 2023 - GE Vernova’s Gas Power business (NYSE: GE) today announced orders for both the supply and the operation and maintenanc

For media inquiries, please contact:

Laura Aresi
Public Relations Leader, Gas Power
GE Vernova
[email protected]
business unit
tags
Press Release

UW–Madison To Perform the First U.S. Evaluation of GE Healthcare’s Photon Counting CT Technology with Deep Silicon Detectors

November 21, 2022
  • GE Healthcare’s design for Deep Silicon detectors for a photon counting CT (PCCT) is engineered with the goal of achieving breakthroughs in both CT spatial and spectral resolution at the same time and increasing imaging performance across care areas
  • Researchers at the University of Wisconsin–Madison will kick off research scanning human subjects with GE Healthcare’s latest generation PCCT prototype in December 2022, representing the first U.S.

    For media inquiries, please contact:

    Margaret Steinhafel
    1 608 381 8829
    [email protected]
    business unit
Press Release

GE Healthcare Introduces Omni Legend: A First-of-its-Kind All-Digital PET/CT System to Drive Efficiency, Enhance Diagnostics, and Deliver on Precision Medicine

October 16, 2022
Press Release

Healthcare Is Personal: GE Healthcare’s Total Molecular Imaging Solutions Enable Precision Health & Theranostics for Personalized Prostate Cancer Care

June 09, 2022
  • At the Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2022 Annual Meeting, GE Healthcare proudly showcases cutting-edge solutions spanning the care continuum and enabling theranostics in prostate cancer
  • This includes a new cyclotron Solid Target Platform which increases Gallium-68 production and access – a radioisotope used in molecular imaging for prostate cancer diagnosis, staging and monitoring
  • The company also celebrates its 500th GE Healthcare cyclotron installation, a type of compact particle accelerator that produces radioisotopes fo

    For media inquiries, please contact:

    Margaret Steinhafel
    GE Healthcare
    +1 608 381 8829
    [email protected]
    business unit
Press Release

GE Healthcare, Medtronic partnership accelerates global access to personalized care by delivering advanced patient monitoring solutions on the CARESCAPE platform

June 01, 2022
  • GE Healthcare, Medtronic receive FDA 510(k) clearance and CE Mark approval on the integration of advanced INVOS™ regional oximetry and Microstream™ capnography technologies on the CARESCAPE precision monitoring platform
  • Helping providers improve patient outcomes and safety, Microstream™ capnography (CO2) technology captures evolving respiratory compromise while INVOS™ regional oximetry (rSO2) technology helps clinicians predict and prevent perioperative complications quicker than traditional peripheral measurement[i],[ii]<

    For media inquiries, please contact:

    Jennifer Purdue
    Communications Director
    GE Healthcare
    +1-267-593-9735
    [email protected]
    Tammy Hudson
    Public Relations
    Medtronic
    +1-678-488-5337
    Ryan Weispfenning
    Investor Relations
    Medtronic
    +1-763-505-4626
    business unit
Press Release

A Bold New World: GE Healthcare’s Pioneering Deep Learning Image Reconstruction Technology Benefits More Than 2 Million Patients Globally

May 06, 2022
Press Release

GE Healthcare Introduces An Industry-First Modular, Scalable CT Platform to Minimize Technology Obsolescence & Maximize Clinical Capabilities

November 29, 2021
  • GE Healthcare introduces the industry’s first[i] computed tomography (CT) platform with built-in scalability and upgradability[ii]
  • The new Revolution Apex platform offers the world’s fastest gantry speed: 0.23 seconds per rotation and 19.5 millisecond effective temporal resolution to freeze cardiac motion[iii]
  • Altogether, the company’s CT platform enables healthcare facilities to keep up with the latest technology while minimizing technology obsolescence, optimizing clinical capabilities, and st

    For media inquiries, please contact:

    Margaret Steinhafel
    +1 608 381 8829
    [email protected] 
    America/Chicago
    business unit
Press Release

Karolinska Institutet & MedTechLabs Kickoff The World’s First Clinical Evaluation of GE Healthcare’s Photon Counting CT Technology with Deep Silicon Detectors

November 17, 2021
  • Photon counting CT has the promise to further expand the capabilities of traditional CT
  • Karolinska Institutet and MedTechLabs’ pilot study represents the first of its kind to test pure silicon CT detector technology for photon counting CT in a clinical setting
  • The project is the result of close collaborations between healthcare, academia and business

Chicago, November 17, 2021: Karolinska Institutet and MedTechLabs recently started testing the world’s fir

For media inquiries, please contact:

Margaret Steinhafel
1 608 381 8829
[email protected]
business unit
Press Release

GE Healthcare Debuts MyoSPECT, A Next-Generation Nuclear Medicine Cardiology System That Gets to the Heart of Challenging Cardiovascular Cases

September 29, 2021
  • Accommodates a greater variety of patients and provides a more complete look at every patient’s heart with enhanced scanning capabilities, including a 76 percent increase in field-of-view volume[i]
  • Leverages GE Healthcare’s exclusive Alcyone technology, which can view cardiac anatomy and pathology with great clarity and speed
  • Introduces several new automated features to help simplify workflows and expedite exams

CHICAGO – September 29, 2021 – GE Healthcare is

For media inquiries, please contact:

Margaret Steinhafel
GE Healthcare
+1 608 381 8829
[email protected]
business unit
Subscribe to Ireland